HOME › Research Insight › New Revenue Pockets for the Pediatric Interventional Cardiology Market
New Revenue Pockets for the Pediatric Interventional Cardiology Market
Across the globe, the adoption of pediatric interventional cardiology devices is increasing, due to factors such as the increasing incidences of congenital heart defects and advancements in technology. A number of pediatric interventional cardiology devices are available in the market. Moreover, market players are engaged in developing new devices with advanced features that will help the market to grow further.
The transcatheter heart valves market showcases a lucrative growth potential and is a new revenue pocket for players in this market; this market includes transcatheter aortic valves and transcatheter pulmonary valves. Taking into consideration the growing demand for transcatheter heart valves, various venture capitalists are investing in this market. For instance, in July 2013, Gimv (Belgium), Legend Capital (China), and Omega Funds (U.S.) invested $62.5 million in JenaValve Technology, Inc. (Germany), for the development of transcatheter aortic valves. Furthermore, the transcatheter heart valves market is witnessing a number of technological advancements and receiving regulatory approvals, owing to which, various new products are being launched in the market. Edwards Lifescineces, a major player in the market, is investing in this market to expand its manufacturing facilities in order to meet the rising global demand for transcatheter heart valves. All these factors have presented an array of opportunities for the transcatheter heart valve market to flourish in the coming years.
Growth in the pediatric interventional cardiology market is likely to be centered at China, Singapore, India, Australia, and New Zealand. Various foreign companies are increasingly investing in and collaborating with local companies to develop and commercialize their products in these regions. For instance, in October 2013, Royal Philips (Netherlands) and RealView Imaging Ltd. (Israel) successfully completed the clinical trial of the 3D holographic visualization and interaction technology. This technology will be used to guide cardiologists by providing live 3D images during interventional cardiology procedures (in both adult and pediatric patients). Furthermore, most of the transcatheter heart valve manufacturers consider APAC as a high-growth region and are therefore launching their products in these markets. These investments and the introduction of innovative products in the APAC market are likely to propel the growth of this market in the coming years.
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252